Guy Leaver, Neoss Chief Financial Officer, talked to Dental Tribune about the company’s history, products and future plans
Neoss was founded in 2000 by CTO, Fredrik Engman and Professor Neil Meredith and is head quartered in Harrogate, North Yorkshire, in the United Kingdom. The business has operations in Australia, Austria, Germany, Italy, New Zealand Sweden and the USA. In recent years the expansion has been via appointed distributors in Europe, Asia and now the Middle East.
This continued expansion has propelled the business forward with sales in constant currency increasing year on year since it was founded.
Guy Leaver stated “We are very proud of our business, our European heritage, Neoss products are all manufactured in Europe, Switzerland and the UK and are manufactured to the highest quality”. Neoss products are developed by its Product Development and Research team and they always aim to develop products which are innovative and market leading. Neoss ProActive Implants are manufactured in Sweden and are protected by 3 patents, the macro geometry, thread forming and cutting, abutment connection and ProActive Surface. The Neoss ProActive surface was introduced in 2009 and creates a surface with dual roughness yet it is also superhydrophilic. This surface enhances protein aggregation and can accelerate fibrin network formation. Studies show the etched and blasted ProActive surface stimulates bone to form more rapidly and with a greater strength at the implant interface. Neoss launched its Neoss ProActiveTapered Implant in 2012, to add to the Neoss ProActive Straight Implant.
Neoss states its objective is to “Advance the Science of Dental Implant Treatment” and that the “Neoss Dental Implant System is the most efficient dental implant system in the market. It combines market-leading functionality for the patient with the lowest level of complexity available for the Surgeon.”
Neoss aims to continue its expansion in the Middle East and has built a strong team in a short time, which should enable the business to support more Distributors and Clinicians in the region.